JP2015512926A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015512926A5 JP2015512926A5 JP2015504977A JP2015504977A JP2015512926A5 JP 2015512926 A5 JP2015512926 A5 JP 2015512926A5 JP 2015504977 A JP2015504977 A JP 2015504977A JP 2015504977 A JP2015504977 A JP 2015504977A JP 2015512926 A5 JP2015512926 A5 JP 2015512926A5
- Authority
- JP
- Japan
- Prior art keywords
- phospholipid
- use according
- surfactant
- vesicle
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1206486.1 | 2012-04-12 | ||
| GBGB1206486.1A GB201206486D0 (en) | 2012-04-12 | 2012-04-12 | Vesicular formulations and uses thereof |
| PCT/EP2013/057742 WO2013153221A1 (en) | 2012-04-12 | 2013-04-12 | Vesicular formulations for use in the treatment of pain or reduced mobility of a joint |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015512926A JP2015512926A (ja) | 2015-04-30 |
| JP2015512926A5 true JP2015512926A5 (https=) | 2016-06-09 |
Family
ID=46208989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015504977A Pending JP2015512926A (ja) | 2012-04-12 | 2013-04-12 | 関節の疼痛または低減した可動性の治療用の小胞製剤 |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US20150065461A1 (https=) |
| EP (1) | EP2836203B1 (https=) |
| JP (1) | JP2015512926A (https=) |
| KR (1) | KR102204725B1 (https=) |
| CN (1) | CN104363894B (https=) |
| AU (1) | AU2013246822A1 (https=) |
| BR (1) | BR112014025507B1 (https=) |
| CA (1) | CA2870111A1 (https=) |
| CL (1) | CL2014002706A1 (https=) |
| CO (1) | CO7141430A2 (https=) |
| DK (1) | DK2836203T3 (https=) |
| EA (1) | EA039626B1 (https=) |
| ES (1) | ES2916803T3 (https=) |
| GB (2) | GB201206486D0 (https=) |
| HR (1) | HRP20220700T1 (https=) |
| HU (1) | HUE058972T2 (https=) |
| IL (1) | IL234862A0 (https=) |
| IN (1) | IN2014DN08259A (https=) |
| LT (1) | LT2836203T (https=) |
| MX (1) | MX2014012198A (https=) |
| PH (1) | PH12014502079A1 (https=) |
| PL (1) | PL2836203T3 (https=) |
| PT (1) | PT2836203T (https=) |
| SG (1) | SG11201406251VA (https=) |
| SI (1) | SI2836203T1 (https=) |
| WO (1) | WO2013153221A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100255080A1 (en) * | 2009-04-02 | 2010-10-07 | Sesvalia Usa, Llc | Liposomal ALA pharmaceutical and cosmeceutical compositions and methods of treatment |
| GB2486371A (en) | 2009-08-21 | 2012-06-13 | Targeted Delivery Technologies Ltd | Vesicular formulations |
| GB201205642D0 (en) | 2012-03-29 | 2012-05-16 | Sequessome Technology Holdings Ltd | Vesicular formulations |
| GB201505532D0 (en) * | 2015-03-31 | 2015-05-13 | Sequessome Technology Holdings Ltd | Formulations |
| ES2895910T3 (es) | 2015-06-30 | 2022-02-23 | Sequessome Tech Holdings Limited | Composiciones multifásicas |
| IL272630B2 (en) * | 2017-08-22 | 2023-09-01 | Moebius Medical Ltd | Liposomal formulations for joint lubrication |
| EP3681479B1 (en) | 2017-09-15 | 2024-01-31 | Dyve Biosciences, Inc. | Sodium bicarbonate for use in the treatment of gout and related disorders |
| CN110314137B (zh) * | 2018-03-30 | 2022-04-05 | 北京泰德制药股份有限公司 | 一种含有脂质囊泡的冻干制剂 |
| KR102912060B1 (ko) | 2021-09-17 | 2026-01-14 | 서울대학교산학협력단 | 골관절염 예방 또는 치료용 약학 조성물 및 건강기능식품 |
| CA3266614A1 (en) | 2023-01-19 | 2024-07-25 | Moebius Medical Ltd. | LONG-ACTING LIPOSOMAL COMPOSITION FOR THE TREATMENT OF PAIN IN JOINT DISORDERS |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2139757C (en) * | 1992-07-08 | 2009-04-14 | Gunther Maierhofer | Liposomes, method of preparing the same and use thereof in the preparation of drugs |
| AUPN723395A0 (en) * | 1995-12-19 | 1996-01-18 | Macnaught Medical Pty Limited | Lubrication methods |
| PL367337A1 (pl) * | 2001-05-31 | 2005-02-21 | Pharmacia Corporation | Przenikająca przez skórę kompozycja selektywnego inhibitora cyklooksygenazy-2 |
| US20050123593A1 (en) * | 2001-06-25 | 2005-06-09 | Jonathan Thompson | Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints |
| US7115666B2 (en) * | 2002-10-15 | 2006-10-03 | Renovis, Inc. | Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain |
| CA2664944C (en) * | 2006-09-28 | 2016-06-14 | Hadasit Medical Research Services & Development Limited | Use of glycerophospholipids for joint lubrication |
| CN105434353A (zh) * | 2009-06-03 | 2016-03-30 | 斯昆申技术控股有限责任公司 | 用于治疗深部组织疼痛的制剂 |
| GB2486371A (en) * | 2009-08-21 | 2012-06-13 | Targeted Delivery Technologies Ltd | Vesicular formulations |
| EP2340819A1 (en) * | 2009-12-23 | 2011-07-06 | Laboratorios Del. Dr. Esteve, S.A. | Compositions comprising venlafaxine and celecoxib in the treatment of pain |
| US9125786B2 (en) * | 2011-03-31 | 2015-09-08 | Phillip Anthony FEMANO | Method and device to alleviate carpal tunnel syndrome and dysfunctions of other soft tissues |
| EP2971075B1 (en) * | 2013-03-13 | 2018-08-15 | Roche Diagnostics GmbH | Methods and compositions for detecting mutations in the human pi3kca (pik3ca) gene |
-
2012
- 2012-04-12 GB GBGB1206486.1A patent/GB201206486D0/en not_active Ceased
-
2013
- 2013-04-12 GB GB1419074.8A patent/GB2515439B/en not_active Expired - Fee Related
- 2013-04-12 DK DK13715989.3T patent/DK2836203T3/da active
- 2013-04-12 CN CN201380031159.3A patent/CN104363894B/zh not_active Expired - Fee Related
- 2013-04-12 LT LTEPPCT/EP2013/057742T patent/LT2836203T/lt unknown
- 2013-04-12 US US14/391,754 patent/US20150065461A1/en not_active Abandoned
- 2013-04-12 EP EP13715989.3A patent/EP2836203B1/en active Active
- 2013-04-12 HR HRP20220700TT patent/HRP20220700T1/hr unknown
- 2013-04-12 WO PCT/EP2013/057742 patent/WO2013153221A1/en not_active Ceased
- 2013-04-12 MX MX2014012198A patent/MX2014012198A/es unknown
- 2013-04-12 SG SG11201406251VA patent/SG11201406251VA/en unknown
- 2013-04-12 EA EA201491583A patent/EA039626B1/ru unknown
- 2013-04-12 ES ES13715989T patent/ES2916803T3/es active Active
- 2013-04-12 JP JP2015504977A patent/JP2015512926A/ja active Pending
- 2013-04-12 IN IN8259DEN2014 patent/IN2014DN08259A/en unknown
- 2013-04-12 HU HUE13715989A patent/HUE058972T2/hu unknown
- 2013-04-12 PT PT137159893T patent/PT2836203T/pt unknown
- 2013-04-12 CA CA2870111A patent/CA2870111A1/en not_active Abandoned
- 2013-04-12 SI SI201331990T patent/SI2836203T1/sl unknown
- 2013-04-12 BR BR112014025507-5A patent/BR112014025507B1/pt not_active IP Right Cessation
- 2013-04-12 KR KR1020147031478A patent/KR102204725B1/ko not_active Expired - Fee Related
- 2013-04-12 AU AU2013246822A patent/AU2013246822A1/en not_active Abandoned
- 2013-04-12 PL PL13715989T patent/PL2836203T3/pl unknown
-
2014
- 2014-09-22 PH PH12014502079A patent/PH12014502079A1/en unknown
- 2014-09-28 IL IL234862A patent/IL234862A0/en unknown
- 2014-10-08 CL CL2014002706A patent/CL2014002706A1/es unknown
- 2014-11-12 CO CO14249925A patent/CO7141430A2/es unknown
-
2016
- 2016-11-11 US US15/349,792 patent/US20170128473A1/en not_active Abandoned
-
2021
- 2021-01-06 US US17/142,624 patent/US20210393655A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015512926A5 (https=) | ||
| HRP20220700T1 (hr) | Vezikularne formulacije za uporabu u liječenju boli ili smanjene pokretljivosti zgloba | |
| BR112015021417A2 (pt) | película de formação de gel dissolúvel, para o fornecimento de agentes ativos | |
| BRPI1010861A8 (pt) | métodos para tratamento de dor, inflamação ou osteoartrite, pacote e formulação farmacêutica | |
| BR112013002601A2 (pt) | corticosteróides para o tratamento de dor em articulação | |
| BR112014004460A2 (pt) | material polimérico para um recipiente isolado | |
| MX356507B (es) | Emulsiones de polimero de agua-en-aceite de inversion rapida. | |
| BR112015017405A2 (pt) | composições que incluem agentes hidrofobizantes e estabilizantes e métodos para preparação e utilização das mesmas | |
| CL2020000220A1 (es) | Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial. | |
| PE20110330A1 (es) | Composicion topica para el tratamiento de queratosis actinica | |
| PE20171334A1 (es) | Formulacion en polvo nasal para el tratamiento de hipoglicemia | |
| HRP20211983T1 (hr) | Pripravci za i postupci stimuliranja matičnih stanica | |
| BR112013004829A2 (pt) | composição de agente de dispersão de produto químico agrícola, composição química agrícola, método para produzir um produto agrícola, método para aumentar eficácia em um produto químico agrícola, e uso da composição de agente de dispersão de produto químico agrícola. | |
| BR112018012183A2 (pt) | composição cosmética e seu uso, formulação cosmética | |
| BR112015011180A2 (pt) | sistema de absorção de fluido unitário para produtos absorventes e seus métodos de fabricação | |
| ES2895910T3 (es) | Composiciones multifásicas | |
| MX389336B (es) | Formulacion farmaceutica. | |
| MX2016007370A (es) | Agente terapeutico y/o preventivo que comprende un derivado de 1-indansulfamida para el dolor. | |
| MX366277B (es) | Composiciones de agente activo retinoide particuladas, secas y finas y formulaciones topicas que incluyen las mismas. | |
| CL2020000221A1 (es) | Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial. | |
| BR112014030553A2 (pt) | uso cosmético, como agente para prevenir e/ou tratar um defeito estético na pele e/ou seus apêndices, método relacionado, composto, e composição dermatológica | |
| BR112015025726A2 (pt) | composição multi-funcional para formulações cosméticas | |
| BR112013024863A2 (pt) | formulação injetável de liberação sustentada | |
| BR112016029996A2 (pt) | utilização cosmética, composição e método cosmético para tratar os odores corporais | |
| MX366097B (es) | Mezclas conservantes sinergicas. |